NCT07096414 Effect of Vitamin D3 Supplementation on Brain Waves in Male Epileptic Patients With Hypovitaminosis D
| NCT ID | NCT07096414 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bangladesh Medical University |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-07-19 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-07-19 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an experimental study (interventional self-controlled trial, pretest-post test design). The goal of this clinical trial is to evaluate the effect of vitamin D3 supplementation on quantitative EEG in male epileptic patients with hypovitaminosis D. . The main question it aims to answer is: Vitamin D3 supplementation has effect on brain waves in male epileptic patients with hypovitaminosis D. Researcher will compare the effect of Vitamin D3 supplementation on brain waves in male epileptic patients with hypovitaminosis D with their pre-intervention (baseline) condition on brain waves to assess whether there will be any improvement of brain electrical activity by quantitative electroencephalogram (QEEG). Participants will: Take Vitamin D3 orally for 8 weeks (50,000IU/week) Visit the medical university after 8 weeks for evaluation of serum 25 (OH) D level and quantitative electroencephalogram (QEEG) Must bring the empty strips of Vitamin D supplement with them during their visit
Eligibility Criteria
Inclusion Criteria: * Diagnosed male patients with Epilepsy by neurologist from the Out Patient Department of Department of Neurology, BMU by taking proper history of at least two unprovoked (or reflex) seizures occurring \> 24 hours apart, from patients and eye witnesses. * Hypovitaminosis D (\<30 ng/ml) * BMI : 20 - 24 kg/m² * On antiepileptic medication for 6 months to 2 years (enzyme inducing AEDs, e.g. Carbamazepine, Phenytoin, Phenobarbital) * Without any medication that affect central nervous system other than antiepileptic drugs (Antidepressants, Antipsychotic, Anxiolytic, Anesthetic drugs) * Apparently normal physical health Exclusion Criteria: * Patients suffering from absence seizure * Certain AEDs (Sodium valproate, Ethosuximide, Oxcarbazepine, Topiramate, Lamotrigine, Levetiracetam) * Smoker * Alcoholic * Known hypersensitivity to vitamin D3 * Patients with hypertension * Patient with Thyroid disorder * Patient with Diabetes mellitus * Patient with Renal Disease * Patient with liver Disease * Patient with hypercalcemia
Contact & Investigator
Dr.Sumayya Binte Abdur Razzaque, MBBS, MD Resident (Phase B)
PRINCIPAL INVESTIGATOR
BMU
Frequently Asked Questions
Who can join the NCT07096414 clinical trial?
This trial is open to male participants only, aged 20 Years or older, up to 40 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07096414 currently recruiting?
Yes, NCT07096414 is actively recruiting participants. Contact the research team at registrar@bsmmu.edu.bd for enrollment information.
Where is the NCT07096414 trial being conducted?
This trial is being conducted at Dhaka, Bangladesh.
Who is sponsoring the NCT07096414 clinical trial?
NCT07096414 is sponsored by Bangladesh Medical University. The principal investigator is Dr.Sumayya Binte Abdur Razzaque, MBBS, MD Resident (Phase B) at BMU. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.